首页> 外国专利> Selective apoptosis induction in cancer cells, including activation of procaspase-3

Selective apoptosis induction in cancer cells, including activation of procaspase-3

机译:选择性诱导癌细胞凋亡,包括激活procaspase-3

摘要

Compounds and related methods for synthesis, and the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed in connection with modification of procaspases such as procaspase-3, and particular embodiments are capable of direct activation of procaspase-3 and procaspase-7 to the effector forms of caspase-3 and caspase-7. Procaspase-3 levels can vary among cancer cell types; several types have relatively high levels and can have increased susceptibility to chemotherapy by compounds and methods herein. Therapeutic applications are relevant for a variety of cancer conditions and cell types, e.g. breast, lung, brain, colon, renal, adrenal, melanoma, and others.
机译:公开了化合物和用于合成的相关方法,以及化合物在治疗癌症中的治疗中的用途以及细胞中细胞凋亡的选择性诱导。公开了与诸如procaspase-3之类的procaspase的修饰有关的化合物,并且特定的实施方案能够将procaspase-3和procaspase-7直接活化为caspase-3和caspase-7的效应子形式。 Procaspase-3水平可能因癌细胞类型而异。几种类型具有相对较高的水平,并且可以通过本文的化合物和方法增加对化学疗法的敏感性。治疗应用与多种癌症状况和细胞类型有关,例如乳腺,肺,脑,结肠,肾,肾上腺,黑素瘤等。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号